Figure_2.tif (135.32 kB)
Enrolment criteria for the post-treatment study population.
figure
posted on 2012-08-28, 01:31 authored by Marcus Beissner, Dominik Symank, Richard Odame Phillips, Yaw Ampem Amoako, Nana-Yaa Awua-Boateng, Fred Stephen Sarfo, Moritz Jansson, Kristina Lydia Huber, Karl-Heinz Herbinger, Florian Battke, Thomas Löscher, Ohene Adjei, Gisela BretzelFigure 2 describes enrolment criteria for IS2404 PCR confirmed BUD patients with incomplete wound healing (collection of swab samples feasible) who presented at Agogo Presbyterian Hospital, Ghana (n = 7), following completion of 56 doses of rifampicin and streptomycin administered within eight weeks. None of the eligible study participants was excluded.
